View Financial HealthSipp Industries 配当と自社株買い配当金 基準チェック /06Sipp Industries配当金を支払った記録がありません。主要情報n/a配当利回りn/aバイバック利回り総株主利回りn/a将来の配当利回りn/a配当成長n/a次回配当支払日n/a配当落ち日n/a一株当たり配当金n/a配当性向n/a最近の配当と自社株買いの更新更新なしすべての更新を表示Recent updatesお知らせ • Jun 25Sipp Industries, Inc. Announces Chief Executive Officer ChangesSIPP Industries, Inc. announced the appointment of Adam Graziano as the new Chief Executive Officer, effective immediately. Jakob Jorgensen, the former CEO of SIPP Industries, will remain a business consultant while also joining Calypso Pharmaceuticals as their new CEO. Mr. Jorgensen's new role will focus on advancing the recent research and development agreement between Calypso Pharmaceuticals and SIPP Industries. This collaboration aims to develop a groundbreaking topical treatment utilizing Peptide P16, designed to penetrate and destroy melanoma cells. Additionally, the partnership will explore the potential of other peptides in combating obesity, anxiety, Alzheimer’s disease, and various other conditions. Adam Graziano brings a wealth of experience and leadership to SIPP Industries. With 20 years in various business leadership roles and over 33 years in the insurance sector, while currently managing a $500 million portfolio, Mr. Graziano has consistently demonstrated his ability to guide teams in achieving and surpassing growth and financial objectives. He holds a Bachelor of Arts in Political Science with a minor in Criminal Justice from St. Cloud State University.お知らせ • Jun 16Sipp Industries Announces Newly Released Delta-8 Sauces, Tea, Fruit Punch and Medicinal Pain LotionSipp Industries, Inc. announced that it has developed and manufactured a new line of Delta-8 (“D8”) infused sauces under the “Sauz” brand. The Company recently completed its first production run of Major Hemp D8 Sweet Lemon Tea and Fruit Punch which will be placed in retail coolers throughout the south-central states with national distribution plans underway at additional distributors. Sipp Industries also reports it officially fulfilled its first orders for the newly developed THC-infused pain lotion under the Aveina brand. With Aveina being the first THC product launch it will exclusively be sold in dispensaries throughout the state of Oklahoma. In April, Sipp Industries began the development and manufacturing process for its new line of Sauz D8 infused sauces. Inspired from an inquiry with a large prospect, Sipp Industries developed a variety of D8 nano-infused sauce flavors including BBQ, Chipotle, Siracha, Buffalo and Steak. These new 10oz sauces pack a powerful punch with 1,000mg of nano emulsified D8 providing an uplifting and euphoric eating experience with your favorite foods. Sipp Industries is planning sampling events at BBQ competitions/cook-offs and other “canna-competitions” for edibles and beverages throughout the summer. The Company is also pursuing brand ambassadors to penetrate the cannabis-infused cuisine market which has become extremely popular for celebrity chefs on Netflix shows such as Bong Appetite and Cooking on High.お知らせ • May 06Sipp Industries Introduces New THC Nano-Infused Medicinal Body LotionSipp Industries, Inc. received an order for its newly developed THC Nano-Infused Body Lotion which will be branded and marketed under the Aveina brand. Over the past several weeks, Sipp Industries formulated and developed its first THC product which is a medicinal grade body lotion used for pain relief, anti-inflammatory, anti-aging, and anti-cancer applications. Aveina is expected to be on the shelves by the end of the month at legally operated medical marijuana dispensaries throughout the state of Oklahoma. Sipp Industries has partnered with its exclusive distributor, Argent Cannabis. Aveina will be sold in 4 oz sizes containing a potent 500mg of Nano THC. With 95% THC bioavailability, Aveina provides fast acting, effective pain relief.お知らせ • Feb 04Sipp Industries Announces First Product Launch of 2022Sipp Industries, Inc. announced the launch of its first product of the year, Nano CBN Drops, addressing the growing cannabis sleep aid market. Sipp Industries has finalized its formula with the primary ingredient being high-grade nano emulsified CBN (cannabidiol). Similar to CBD, the benefits of CBN include anti-inflammatory, pain relief and enhanced sleep quality. These drops will be in 100mg and 200mg dosages which can be added sublingually or in any choice of beverage. The CBN drops are completely water-soluble that contribute to the increasing bioavailability and effects. Approximately 30% to 48% of older adults suffer from insomnia. The cumulative long-term effects of sleep disorders have been found to cause increased risks of depression, hypertension, obesity, diabetes, heart attack, and stroke. Sipp Industries plans to market Nano Drops worldwide through both online sales and traditional distribution channels.お知らせ • Jan 05Sipp Industries, Inc. (OTCPK:SIPC) acquired 5% stake in Calypso Extracts.Sipp Industries, Inc. (OTCPK:SIPC) acquired 5% stake in Calypso Extracts on January 4, 2022. Under the terms of the agreement, Sipp Industries had acquired a 5% stake in Calypso, with an option to acquire up to 10% within 12 months. Sipp Industries, Inc. (OTCPK:SIPC) completed the acquisition of 5% stake in Calypso Extracts on January 4, 2022.お知らせ • Aug 21Sipp Industries, Inc. Announces Appointment of Nick Pelletiere as Acting Chief Executive OfficerSipp Industries, Inc. announced appointment of Nick Pelletiere as its new Acting Chief Executive Officer. Mr. Pelletiere offers a history of profitable business ventures. He has a proven track record in driving the rapid growth and development of small and medium-sized businesses, as well as large corporations, resulting in significant increases in revenue and market share. He offers dynamic and results-driven sales with 25+ years of sales experience across various industries, marketing, and management experience as well as ownership in business partnerships. Mr. Pelletiere has a very entrepreneurial, enthusiastic, and passionate mindset to generate leads, pursue and secure new business opportunities, as well as meet and exceed sales targets.決済の安定と成長配当データの取得安定した配当: SIPCの 1 株当たり配当が過去に安定していたかどうかを判断するにはデータが不十分です。増加する配当: SIPCの配当金が増加しているかどうかを判断するにはデータが不十分です。配当利回り対市場Sipp Industries 配当利回り対市場SIPC 配当利回りは市場と比べてどうか？セグメント配当利回り会社 (SIPC)n/a市場下位25% (US)1.4%市場トップ25% (US)4.2%業界平均 (Electrical)0.6%アナリスト予想 (SIPC) (最長3年)n/a注目すべき配当: SIPCは最近配当金を報告していないため、配当金支払者の下位 25% に対して同社の配当利回りを評価することはできません。高配当: SIPCは最近配当金を報告していないため、配当金支払者の上位 25% に対して同社の配当利回りを評価することはできません。株主への利益配当収益カバレッジ: SIPCの 配当性向 を計算して配当金の支払いが利益で賄われているかどうかを判断するにはデータが不十分です。株主配当金キャッシュフローカバレッジ: SIPCが配当金を報告していないため、配当金の持続可能性を計算できません。高配当企業の発掘7D1Y7D1Y7D1YUS 市場の強力な配当支払い企業。View Management企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/05/22 14:37終値2026/05/22 00:00収益2011/12/31年間収益2011/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Sipp Industries, Inc. 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。0
お知らせ • Jun 25Sipp Industries, Inc. Announces Chief Executive Officer ChangesSIPP Industries, Inc. announced the appointment of Adam Graziano as the new Chief Executive Officer, effective immediately. Jakob Jorgensen, the former CEO of SIPP Industries, will remain a business consultant while also joining Calypso Pharmaceuticals as their new CEO. Mr. Jorgensen's new role will focus on advancing the recent research and development agreement between Calypso Pharmaceuticals and SIPP Industries. This collaboration aims to develop a groundbreaking topical treatment utilizing Peptide P16, designed to penetrate and destroy melanoma cells. Additionally, the partnership will explore the potential of other peptides in combating obesity, anxiety, Alzheimer’s disease, and various other conditions. Adam Graziano brings a wealth of experience and leadership to SIPP Industries. With 20 years in various business leadership roles and over 33 years in the insurance sector, while currently managing a $500 million portfolio, Mr. Graziano has consistently demonstrated his ability to guide teams in achieving and surpassing growth and financial objectives. He holds a Bachelor of Arts in Political Science with a minor in Criminal Justice from St. Cloud State University.
お知らせ • Jun 16Sipp Industries Announces Newly Released Delta-8 Sauces, Tea, Fruit Punch and Medicinal Pain LotionSipp Industries, Inc. announced that it has developed and manufactured a new line of Delta-8 (“D8”) infused sauces under the “Sauz” brand. The Company recently completed its first production run of Major Hemp D8 Sweet Lemon Tea and Fruit Punch which will be placed in retail coolers throughout the south-central states with national distribution plans underway at additional distributors. Sipp Industries also reports it officially fulfilled its first orders for the newly developed THC-infused pain lotion under the Aveina brand. With Aveina being the first THC product launch it will exclusively be sold in dispensaries throughout the state of Oklahoma. In April, Sipp Industries began the development and manufacturing process for its new line of Sauz D8 infused sauces. Inspired from an inquiry with a large prospect, Sipp Industries developed a variety of D8 nano-infused sauce flavors including BBQ, Chipotle, Siracha, Buffalo and Steak. These new 10oz sauces pack a powerful punch with 1,000mg of nano emulsified D8 providing an uplifting and euphoric eating experience with your favorite foods. Sipp Industries is planning sampling events at BBQ competitions/cook-offs and other “canna-competitions” for edibles and beverages throughout the summer. The Company is also pursuing brand ambassadors to penetrate the cannabis-infused cuisine market which has become extremely popular for celebrity chefs on Netflix shows such as Bong Appetite and Cooking on High.
お知らせ • May 06Sipp Industries Introduces New THC Nano-Infused Medicinal Body LotionSipp Industries, Inc. received an order for its newly developed THC Nano-Infused Body Lotion which will be branded and marketed under the Aveina brand. Over the past several weeks, Sipp Industries formulated and developed its first THC product which is a medicinal grade body lotion used for pain relief, anti-inflammatory, anti-aging, and anti-cancer applications. Aveina is expected to be on the shelves by the end of the month at legally operated medical marijuana dispensaries throughout the state of Oklahoma. Sipp Industries has partnered with its exclusive distributor, Argent Cannabis. Aveina will be sold in 4 oz sizes containing a potent 500mg of Nano THC. With 95% THC bioavailability, Aveina provides fast acting, effective pain relief.
お知らせ • Feb 04Sipp Industries Announces First Product Launch of 2022Sipp Industries, Inc. announced the launch of its first product of the year, Nano CBN Drops, addressing the growing cannabis sleep aid market. Sipp Industries has finalized its formula with the primary ingredient being high-grade nano emulsified CBN (cannabidiol). Similar to CBD, the benefits of CBN include anti-inflammatory, pain relief and enhanced sleep quality. These drops will be in 100mg and 200mg dosages which can be added sublingually or in any choice of beverage. The CBN drops are completely water-soluble that contribute to the increasing bioavailability and effects. Approximately 30% to 48% of older adults suffer from insomnia. The cumulative long-term effects of sleep disorders have been found to cause increased risks of depression, hypertension, obesity, diabetes, heart attack, and stroke. Sipp Industries plans to market Nano Drops worldwide through both online sales and traditional distribution channels.
お知らせ • Jan 05Sipp Industries, Inc. (OTCPK:SIPC) acquired 5% stake in Calypso Extracts.Sipp Industries, Inc. (OTCPK:SIPC) acquired 5% stake in Calypso Extracts on January 4, 2022. Under the terms of the agreement, Sipp Industries had acquired a 5% stake in Calypso, with an option to acquire up to 10% within 12 months. Sipp Industries, Inc. (OTCPK:SIPC) completed the acquisition of 5% stake in Calypso Extracts on January 4, 2022.
お知らせ • Aug 21Sipp Industries, Inc. Announces Appointment of Nick Pelletiere as Acting Chief Executive OfficerSipp Industries, Inc. announced appointment of Nick Pelletiere as its new Acting Chief Executive Officer. Mr. Pelletiere offers a history of profitable business ventures. He has a proven track record in driving the rapid growth and development of small and medium-sized businesses, as well as large corporations, resulting in significant increases in revenue and market share. He offers dynamic and results-driven sales with 25+ years of sales experience across various industries, marketing, and management experience as well as ownership in business partnerships. Mr. Pelletiere has a very entrepreneurial, enthusiastic, and passionate mindset to generate leads, pursue and secure new business opportunities, as well as meet and exceed sales targets.